Sven Dethlefs, EVP, North America Commercial at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 17,890 shares at $7.37 ($132K) on 2022-03-07, disclosed to the SEC on 2022-03-08.
Seasonal sale ($132k) by EVP, North America Commercial — this insider has traded TEVA in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.48 | 3,904 | $29K | 22.1% |
| 2 | $7.37 | 6,993 | $52K | 39.0% |
| 3 | $7.37 | 6,993 | $52K | 39.0% |
| Total | $7.39 avg | 17,890 | $132K | 100% |
| Filing → |
| TEVA | SELL | 2022-03-02 | $40K | — | Filing → |
| TEVA | SELL | 2022-02-10 | $37K | — | Filing → |
| TEVA | SELL | 2021-03-08 | $127K | — | Filing → |